decreased UOP : ----if the baseline Creat is < 2.5 mg/dl : ARF if the baseline Creat is < 2.5 mg/dl : ARF can be defined by an increase in serum can be defined by an increase in serum Creatinine of at least Creatinine of at least 0.5 mg/dl 0.5 mg/dl , for 2 weeks , for 2 weeks or less or less ----Or, if the baseline Creat is > 2.5 mg/dl:
Or, if the baseline Creat is > 2.5 mg/dl: ARF can be defined by an increase in serum ARF can be defined by an increase in serum Creatinine Creatinine by more than 20%. by more than 20%.
ARF / AKI ARF / AKI
can be can be nonoliguric nonoliguric or can be or can be oliguric oliguric (oliguria=less than (oliguria=less than 400 ml urine 400 ml urine output/day output/day in adults or less than ½ cc/kg/hr) in adults or less than ½ cc/kg/hr) Anuria Anuria usually has worse prognosis (except usually has worse prognosis (except in dehydration) and is defined as less than in dehydration) and is defined as less than 100 ml/day 100 ml/day of urine output in adults.
of urine output in adults.
ARF occurs in ~ 5% of hospitalized patients. ARF occurs in ~ 5% of hospitalized patients. U Na / P Na U Na / P Na X 100 X 100 U Cr / P Cr U Cr / P Cr , treat with IV bicarbonate: D5W w/ 3 amps NaHCO3/L IV bicarbonate: D5W w/ 3 amps NaHCO3/L at 100 at 100--150ml/hr, titrate to high volume UOP, 150ml/hr, titrate to high volume UOP, and use furosemide to force diuresis. and use furosemide to force diuresis.
Historically, diuretics have often been used Historically, diuretics have often been used to convert oliguric to non to convert oliguric to non--oliguric renal oliguric renal failure. This is of unclear benefit and may failure. This is of unclear benefit and may cause increased mortality. cause increased mortality.
Recent studies show no benefit for use of Recent studies show no benefit for use of renal renal--dose dopamine.
dose dopamine.
PREVENTION PREVENTION
